BioCentury | Sep 25, 2006
Strategy

Midcap wake-up call

...Bjorkland said on a separate conference call. The private company's major shareholders include Nordic Capital, CSFB Private Equity...
BioCentury | Oct 10, 2005
Finance

Ebb & Flow

...Morgan Stanley. Glazer is managing director of ATP Management and formerly was a principal at CSFB Private Equity...
BioCentury | Jan 3, 2005
Finance

Ebb & Flow

...yet completed the process of valuing" itself. Investors in Sunesis' July 2000 C round included CSFB Private Equity...
BioCentury | Jun 23, 2004
Financial News

PTC raises $15 million

...bringing the total raised in the round to $50 million. The round was led by CSFB Private Equity...
BioCentury | May 31, 2004
Company News

Point Therapeutics board of directors update

...Point Therapeutics Inc. (POTP), Boston, Mass. Business: Cancer Appointed: Larry Pickering, global chairman of CSFB Private Equity WIR Staff cancer...
BioCentury | May 3, 2004
Finance

Ebb & Flow

...start to heat up as well." Rodman & Renshaw served as placement agent. Venture tracks CSFB Private Equity...
...& Johnson Development Corp. and a corporate officer with responsibility for corporate mergers and acquisitions. CSFB Private Equity...
BioCentury | Jan 12, 2004
Finance

Ebb & Flow

...B14). Private rounds PTC Therapeutics raised $35 million in a series E round co-led by CSFB Private Equity...
BioCentury | Jan 7, 2004
Financial News

PTC raises $35 million

...PTC Therapeutics raised $35 million in a series E round co-led by CSFB Private Equity and HBM Bioventures...
BioCentury | Apr 28, 2003
Finance

Lessons for an 'up' round

...last venture round was a $55 million series C financing in November 2000. Investors included CSFB Private Equity...
BioCentury | Apr 28, 2003
Top Story

Cytokinetics raises $40 million

...in the round included General American Investors; HBM BioVentures; PRM Ventures; Mizuho Capital; Sevin Rosen; CSFB Private Equity...
Items per page:
1 - 10 of 21
BioCentury | Sep 25, 2006
Strategy

Midcap wake-up call

...Bjorkland said on a separate conference call. The private company's major shareholders include Nordic Capital, CSFB Private Equity...
BioCentury | Oct 10, 2005
Finance

Ebb & Flow

...Morgan Stanley. Glazer is managing director of ATP Management and formerly was a principal at CSFB Private Equity...
BioCentury | Jan 3, 2005
Finance

Ebb & Flow

...yet completed the process of valuing" itself. Investors in Sunesis' July 2000 C round included CSFB Private Equity...
BioCentury | Jun 23, 2004
Financial News

PTC raises $15 million

...bringing the total raised in the round to $50 million. The round was led by CSFB Private Equity...
BioCentury | May 31, 2004
Company News

Point Therapeutics board of directors update

...Point Therapeutics Inc. (POTP), Boston, Mass. Business: Cancer Appointed: Larry Pickering, global chairman of CSFB Private Equity WIR Staff cancer...
BioCentury | May 3, 2004
Finance

Ebb & Flow

...start to heat up as well." Rodman & Renshaw served as placement agent. Venture tracks CSFB Private Equity...
...& Johnson Development Corp. and a corporate officer with responsibility for corporate mergers and acquisitions. CSFB Private Equity...
BioCentury | Jan 12, 2004
Finance

Ebb & Flow

...B14). Private rounds PTC Therapeutics raised $35 million in a series E round co-led by CSFB Private Equity...
BioCentury | Jan 7, 2004
Financial News

PTC raises $35 million

...PTC Therapeutics raised $35 million in a series E round co-led by CSFB Private Equity and HBM Bioventures...
BioCentury | Apr 28, 2003
Finance

Lessons for an 'up' round

...last venture round was a $55 million series C financing in November 2000. Investors included CSFB Private Equity...
BioCentury | Apr 28, 2003
Top Story

Cytokinetics raises $40 million

...in the round included General American Investors; HBM BioVentures; PRM Ventures; Mizuho Capital; Sevin Rosen; CSFB Private Equity...
Items per page:
1 - 10 of 21